Kunming Longjin Pharmaceutical Co.,Ltd. Posted 4.5 Million Yuan Net Loss in First Half of 2022

Kunming Longjin Pharmaceutical Co.,Ltd. (昆明龙津药业股份有限公司) (002750.SZ) reported a net loss of 4.5 million yuan in the first half of 2022, reversing a net profit of 2.4 million yuan for the same period in the previous year.

Meanwhile, the company posted 78.1 million yuan in revenue, down 80.4% year-on-year.

At the end of the reporting period, it had 805.2 million yuan in total assets and 131.4 million yuan in total liabilities, with a liability-to-asset ratio of 16.3%.